Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: DCLK1 LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-02-28 to 2024-02-27
Current total value of award: $353412
Description: SBIR CONCEPT AWARD-NANOSPONGE LINKED DCLK1 INHIBITORS FOR THE TARGETED TREATMENT OF CHOLANGIOCARCINOMA